Literature DB >> 17925048

Illicit drug use and neonatal outcomes: a critical review.

Ashley H Schempf1.   

Abstract

Although the neonatal consequences of tobacco and alcohol exposure are well established, the evidence related to prenatal illicit drug use is less consistent despite prevalent views to the contrary. The many social, psychosocial, behavioral, and biomedical risk factors for adverse birth outcomes associated with illicit drug use complicate the evaluation of neonatal effects. Placing emphasis on recent research, this review summarizes the epidemiologic literature on the neonatal impact of marijuana, opiate, and cocaine use. Of these drugs, cocaine use is most consistently related to fetal growth decrements and dose-response effects have been observed. However, studies to date have largely failed to control for associated social, psychosocial, and contextual factors. Additional recommendations for future research are provided. It is likely that interventions will need to address the factors surrounding drug use to greatly improve neonatal outcomes (e.g., social circumstances, poor nutrition, stress, infections).

Entities:  

Mesh:

Year:  2007        PMID: 17925048     DOI: 10.1097/01.ogx.0000286562.31774.76

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  25 in total

Review 1.  Medical consequences of marijuana use: a review of current literature.

Authors:  Adam J Gordon; James W Conley; Joanne M Gordon
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

Review 2.  Illicit substance use in pregnancy - a review.

Authors:  Katherine Scott; Karin Lust
Journal:  Obstet Med       Date:  2010-09-17

3.  Maternal mental health and children's internalizing and externalizing behaviors: Beyond maternal substance use disorders.

Authors:  Yih-Ing Hser; H Isabella Lanza; Libo Li; Emily Kahn; Elizabeth Evans; Marya Schulte
Journal:  J Child Fam Stud       Date:  2015-03

Review 4.  Pharmacologic management of the opioid neonatal abstinence syndrome.

Authors:  Walter K Kraft; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-08-30       Impact factor: 3.278

Review 5.  Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience.

Authors:  Gordon A Barr; Anika McPhie-Lalmansingh; Jessica Perez; Michelle Riley
Journal:  ILAR J       Date:  2011

6.  Illicit drug use in late pregnancy associated with stillbirth and eclampsia.

Authors:  Katherine Scott; Narelle Fagermo; Leonie Callaway; Karin Lust
Journal:  Obstet Med       Date:  2010-09-17

7.  Alcohol and drug use before and during pregnancy: an examination of use patterns and predictors of cessation.

Authors:  Patricia A Harrison; Abbey C Sidebottom
Journal:  Matern Child Health J       Date:  2008-05-03

Review 8.  Norepinephrine and stimulant addiction.

Authors:  Mehmet Sofuoglu; R Andrew Sewell
Journal:  Addict Biol       Date:  2008-09-22       Impact factor: 4.280

9.  Complex calculations: how drug use during pregnancy becomes a barrier to prenatal care.

Authors:  Sarah C M Roberts; Cheri Pies
Journal:  Matern Child Health J       Date:  2011-04

10.  Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes.

Authors:  S L Kacinko; H E Jones; R E Johnson; R E Choo; M A Huestis
Journal:  Clin Pharmacol Ther       Date:  2008-08-13       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.